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Sleep Disordered Breathing (SDB) during pregnancy is associated with maternal and 
neonatal morbidity, and in-hospital mortality. A recent prevalence study using the 
Nationwide Inpatient Sample reported an obstructive sleep apnea (OSA) prevalence of 
7.3 per 10,000 in 2013, a rate of 24% per year over the last decade. The rise in prevalence 
mirrors the rise in obesity. Military Treatment Facilities (MTF) have seen an increase in 
obesity and related co-morbidities with an unknown prevalence of SDB. Most studies 
have been conducted in high-risk populations; the general prevalence of SDB and its 
association with adverse pregnancy outcomes in a military population needs exploration. 
Methods 
This prospective, observational study used the Facco Four Variable (FFV) model and 
STOP-Bang to screen parturients presenting for delivery at a MTF to determine the 
general prevalence of SDB. Logistic regression on parturient data who screened positive, 
FFV (score ≥75) and STOP-Bang (score ≥ 3) was used to examine if higher rates of 
adverse pregnancy outcomes (gestational hypertension, preeclampsia/eclampsia, 
gestational diabetes, non-elective cesarean delivery, NICU admission, hospital stay >5 
days, a composite variable of adverse pregnancy outcomes) were associated with SDB. 
Demographic and prevalence data were compared between active duty and non-active 






Of the study population (N=295), the FFV identified 12.3% (n=36) and STOP-Bang 
7.1% (n=21) participants at high risk for SDB. Adverse pregnancy outcomes were 
experienced by 58% women with the FFV and 66% with STOP-Bang. Logistic 
regression indicated the FFV categorical score (≥75) was not predictive of adverse 
pregnancy outcomes. Utilizing FFV absolute score, an increased risk of APO was noted 
(adjusted OR=1.03, 95% CI 1.01-1.05, p=.013). Logistic regression indicated a STOP-
Bang score ≥3 was predictive of an adverse pregnancy outcome (adjusted OR=3.26, 95% 
CI 1.23-8.62, p=.018).  
Conclusion 
Findings support the need for routine screening for identification of SDB during 
pregnancy and the opportunity for repeated testing to track progression, treatment, and 
resolution of SDB. Further research is needed to determine critical points in the 
development and management of SDB during pregnancy, if and when SDB resolves after 
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Sleep Disordered Breathing (SDB) is a not-so-silent syndrome that is largely 
undiagnosed, yet has significant implications for health. SDB is often associated with 
loud snoring, older men, and obesity but there is another population who may be at 
significant risk: pregnant women. Pregnancy has been associated with alterations in sleep 
that may come from a number of causes, including SDB (August et al., 2013). There is 
mounting evidence SDB plays a significant role in the morbidity and mortality of 
perinatal outcomes directly involving the nurse anesthetist.  For nurse anesthetists, factors 
associated with SDB, for instance, obesity, preeclampsia, diabetes, difficult intubation, 
cesarean delivery, and sensitivity to anesthetic agents, sedatives, and hypnotics can 
complicate anesthetic care (Chung, Yuan, & Chung, 2008).  Screening for SDB may alert 
the anesthetist to underlying factors that can contribute to an adverse outcome and 
provide essential information to change the anesthetic plan. A confluence of variables 
directly related to the anesthetic plan such as medications and side effects, sleep 
deprivation and fatigue, and lack of monitoring protocols may be placing our patients at 
risk for such catastrophic outcomes as respiratory depression and death. Obesity and 
hypertensive disorders intertwined with SDB may be contributing to cesarean deliveries, 
pre-term deliveries, and low birth weights. Unrecognized and undiagnosed SDB during 
the antenatal time frame may lead to adverse pregnancy outcomes. Without screening for 
SDB in pregnancy we may be overlooking a significant contributor to morbidity and 





Obesity is perhaps the strongest correlate with SDB across all populations. 
Alarmingly, a recent study predicts a 33% increase in the prevalence of obesity over the 
next two decades (Finkelstein et al., 2012). Excess body weight and fat accumulation can 
work in several ways to develop SDB. Fat accumulation can alter upper airway structure, 
increase total body oxygen demand, and decrease functional residual capacity–all of 
which can promote or exacerbate SDB (Young, Peppard, & Gottlieb, 2002). Obesity 
during pregnancy has been associated with increased risk for gestational diabetes, 
preeclampsia, cesarean delivery, macrosomia, low Apgar scores, and still birth (Ovesen, 
Rasmussen, & Kesmodel, 2011). Excess weight gain before or during pregnancy over 
and above Institute of Medicine recommendations is also an independent predictor of 
preeclampsia (O’Brien et al., 2012).  The prevalence of SDB among pregnant women has 
risen dramatically, 24% per year over the past decade, and coincides with the rise in 
obesity rates (J. M. Louis, Mogos, Salemi, Redline, & Salihu, 2014). Similar to obesity, 
SDB is associated with maternal morbidities such as chronic hypertension and diabetes 
mellitus in addition to asthma and depression (Louis, Auckley, Sokol, & Mercer, 2010).  
Obesity and SDB have similar risks for the neonate such as NICU admission (J. Louis, 
Auckley, Miladinovic, et al., 2012), pre-term birth, and cesarean delivery (Bourjeily, 
Ankner, & Mohsenin, 2011). The commonality of such adverse pregnancy outcomes as 
gestational diabetes, preeclampsia, cesarean delivery, pre-term delivery, and NICU 
admission is concerning based on what we already know about the prevalence of obesity 
and what we are learning about the rising prevalence of SDB.  
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Unlike the obstetrician who may have the benefit of establishing a relationship 
and monitoring co-morbidities over several months of the pregnancy, the anesthetist may 
only meet the patient shortly before delivery. Sleep disordered breathing is associated 
with co-morbidities such as obesity, preeclampsia, diabetes, difficult intubation, cesarean 
delivery, and sensitivity to anesthetic agents, sedatives and hypnotics – all of which can 
complicate anesthetic care. The sensitivity to anesthetic agents, sedatives, and hypnotics 
is of particular interest. With a limited window of opportunity to address co-morbidities, 
the nurse anesthetist may be left with few options other than to alter the anesthetic 
technique by reducing the amount of narcotic medications the patient receives–a critical 
component of pain management.  
A large percentage of obstetric anesthesia practice is centered on providing 
neuraxial anesthesia in the form of spinal and epidural solutions of local anesthetic and 
narcotic medications. Preservative-free morphine has been approved for neuraxial 
administration for post-operative analgesia since 1984 and has been used extensively 
(Sultan et al., 2011).  However, there is the potential adverse effect of respiratory 
depression that is significantly concerning. The pharmacokinetics of opioids can be 
complex, especially when comparing interactions or differences between compartments 
such as spinal or epidural and plasma. Epidural pharmacokinetics are especially 
challenging as they may vary by level of insertion (Sultan et al., 2011). Level of insertion 
may vary depending upon patient positioning and anesthesia provider technique. The 
incidence and degree of respiratory depression from neuraxial administration of 
preservative-free morphine is difficult to ascertain in the perinatal period due to 
intermittent monitoring of vital signs–a practice that is often unreliable in predicting 
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respiratory depression (Carvalho, 2008). Screening for SDB may provide additional 
information to the nurse anesthetist that can be used to alter the anesthetic plan. Narcotic 
dosing with spinal anesthetics may be decreased or eliminated based on concerns for 
SDB and a need for additional monitoring. Alternative pain management plans such as 
non-narcotic pain medications and transverse abdominal plane regional anesthesia blocks 
may be used. A study evaluating sleep in the five nights prior to delivery and early labor 
found women with less total sleep time (TST) the night before birth had higher total pain 
scores during labor (Beebe & Lee, 2007). Sleep deprivation may impact the ability to 
tolerate labor pain and could change the timing and duration of epidural pain 
management. Early initiation of an epidural or replacement of a poorly performing one 
based on a risk assessment of SDB may be appropriate. If general anesthesia is required, 
a provider may make extra preparations to prepare for a difficult airway or to decide 
when to extubate. Additional resources and supportive therapies such as continuous 
positive airway pressure (CPAP) and continuous end-tidal carbon dioxide (ETCO2) 
monitoring may be required. Depending upon the hospital or birthing facility size, 
resources for both mother and child may not be sufficient. Transfer of care may be 
required to a facility with a NICU and continuous monitoring capability. Not knowing 
about a condition like SDB and how it interacts with so many crucial aspects of 
anesthesia may be the most dangerous situation of all.   
Purpose and Specific Aims 
 The purpose of this study was to examine the prevalence of Sleep Disordered 
Breathing (SDB) and its association with adverse pregnancy outcomes in pregnant 
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women at delivery using the Facco Four Variable model and the STOP-Bang model at a 
large Military Treatment Facility (MTF). This was achieved through the following aims. 
   
Aim 1: To examine the prevalence of SDB using a cut-score of ≥75 on the 
Facco Four Variable model and a score ≥ 3 on the STOP-Bang model in a 
general obstetric population admitted in the immediate postpartum period 
at a large academic Military Treatment Facility. 
Aim 2: To examine if parturients suspected of having SDB as assessed by the 
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB; 
score ≥ 3) have higher rates of the following adverse maternal child 
outcomes: gestational hypertension, low birth weight <2500 gms, NICU 
admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia, 
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite 
score of adverse pregnancy outcomes, and a composite score of 
cardiopulmonary complications that includes pulmonary embolism, in-
hospital mortality, pulmonary edema, congestive heart failure, and 
cardiomyopathy. 
Aim 3-Exploratory: Compare the prevalence rates of suspected SDB at delivery 






Pregnancy is a time of almost unprecedented change in a woman’s life. When 
viewed through the lens of nursing science (person, environment, health, and illness) all 
aspects undergo significant alterations in a relatively short amount of time. The physical 
and physiologic changes produce a wide range of symptoms that occur throughout the 
pregnancy and can vary from day to day. Symptoms can range from the obvious, such as 
an increase in physical size to an insidious rise in blood pressure. Multiple symptoms 
may be present at any time and arise from multiple conditions. As a woman experiences 
symptoms she must perceive, evaluate, and manage the symptom appropriately. 
 Symptom Management Theory (SMT) was used to guide the study (Humphries et 
al., 2008).  There are three essential concepts that comprise SMT: symptom experience, 
symptom management strategies, and symptom status outcomes. Symptom experience is 
the simultaneous perception, evaluation, and response to a change in how one usually 
feels. Symptom management is the effort to avert, delay, or minimize the symptom 
experience. Symptom status outcomes are measures of how effective the symptom 
management was at decreasing the perceived symptom (Humphries et al., 2008). 
As mentioned previously, there are a number of symptoms of pregnancy. Specific 
to SDB, snoring and daytime sleepiness are symptoms that may develop at any time and 
worsen throughout the pregnancy. These symptoms may present a challenge to manage. 
Snoring may not be noted if a woman lacks a sleep partner or may be perceived as a sign 
of deep sleep– a confusing result when experiencing excessive daytime sleepiness. 
Arousal and sleep fragmentation may result from SDB but be associated with other 
physical discomforts and an inability to enter a restful state. Cultural expectations of 
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fatigue during pregnancy may mask an underlying physiologic cause. The use of SMT 
guides the patient and provider to explore the symptoms of snoring and excessive 
daytime sleepiness, screen and test for SDB, explore options to manage the symptoms 
(minimize weight gain, airway support therapies), and assess management progress with 
testing (at home sleep study).  Through identification and management of the symptoms 
of SDB definitive action can be taken to minimize or alleviate the impact of SDB on the 





Figure 1.  Model of Symptom Management Theory 
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Implications for Nursing Research 
 Disturbance of sleep during pregnancy is not a new phenomenon but the 
relationship between poor sleep and adverse pregnancy outcomes is gaining attention. 
Traditional assumptions and tolerance of poor sleep during pregnancy needs to be 
examined through nursing science. While the time span of pregnancy may be short 
relative to a person’s life span, the stresses and changes that occur may have a greater 
impact on future health than is currently understood. Kestenbaum et al. (2003) examined 
cardiovascular and thromboembolic events after a hypertensive pregnancy. All singleton 
births in Washington State from 1987 to 1989 were examined for diagnosis of gestational 
hypertension, preeclampsia, chronic hypertension, and then linked to later hospital 
admissions. The results showed an increased risk for cardiovascular events such as acute 
myocardial infarction, stroke, deep vein thrombosis, coronary artery revascularization, 
and pulmonary embolism. The associations are as follows: gestational hypertension 2.8 
(95% CI, 1.6-4.8), mild preeclampsia 2.2 (95% CI, 1.3-3.6), and severe preeclampsia 3.3 
(95% CI, 1.7-6.5). Women with hypertensive disorders during pregnancy are at 2-3 times 
greater risk for the development of significant cardiovascular events later in life.  
During a pregnancy, a woman will have multiple exposures to nurses and 
numerous opportunities to be engaged on issues of her health-both short and long term. 
The knowledge and information from these interactions can shape the future health of a 
family. Nursing research is well prepared to provide the science to support these families 






 Pregnancy has been associated with alterations in sleep that may come from a 
number of causes, including Sleep Disordered Breathing (SDB). There is mounting 
evidence SDB plays a significant role in the morbidity and mortality of perinatal 
outcomes. Sleep disordered breathing is a broad term covering a spectrum of disorders 
that effect breathing while sleeping and have a range of physiologic consequences. 
Obstructive sleep apnea (OSA) is a specific form of sleep disordered breathing with 
periods of apnea, oxygen desaturation, excessive daytime sleepiness, and snoring that 
result from airway obstruction (J. Louis, Auckley, Miladinovic, et al., 2012; Quan et al., 
1997). The airway obstruction is from a combination of anatomic and neuromuscular 
factors that in turn are influenced by age, gender, and body habitus (Young, Peppard, & 
Gottlieb, 2002). During pregnancy, a woman may be more likely to develop SDB and 
experience perinatal complications. 
History 
 A review of the literature reveals sleep apnea syndromes have been an area of 
inquiry since the 1970’s (Guilleminault, Tilkian, & Dement, 1976). Research into the 
causes of cardiovascular disease developed links to SDB. Large population studies for 
SDB began and have been instrumental in forming the body of knowledge about SDB 
and pregnancy. Two studies of historical interest are the the Sleep Heart Health Study 
(Quan et al., 1997) and Wisconsin Sleep Cohort Study (Young et al., 2008).  
The Sleep Heart Health Study (SHHS) is an example of early (and ongoing) 
research into links between cardiovascular disease and sleep. The study began in 1994 as 
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a prospective, longitudinal, cohort design investigating cardiovascular disease and the 
independent contribution of sleep apnea. Subjects were recruited from established 
cardiovascular and pulmonary epidemiologic cohort studies already underway throughout 
the country. All subjects were a minimum age of 40 years and predominately male; 
pregnancy was not a focus. A cross sectional analysis was published  to discuss interval 
findings (Gottlieb, 2008).  The relationship between sleep apnea and cardiovascular 
disease showed hypertension strongly associated with even mild OSA and significant 
changes to ventricular morphology resulting in a lower left ventricular ejection fraction. 
The report also describes how the methodology of SDB research has changed as a result 
of the study. The definition of an apnea-hypopnea event, a fundamental variable in SDB 
research, was different based on the amount of oxygen desaturation or presence of 
arousal. Oxygen desaturation could range from 2-5% and the resulting AHI would vary 
from 2.0 events per hour with a 5% desaturation to 17.4 events per hour with a 2% 
desaturation. This resulted in an increase in SDB prevalence of patients with an AHI >15 
from 10% to over 50%. The results of this study prompted the standardization of the 
methodology for diagnosing SDB by the American Academy of Sleep Medicine Manual 
for the Scoring of Sleep and Associated Events.  
The Wisconsin Sleep Cohort Study began in 1988 as a prospective population 
based study on the natural history of SDB (Young et al., 2008). Participants were 
recruited from a sampling of payroll records from state agencies of Wisconsin, were not 
patients, and did not have a diagnosis of SDB. Men and women age 30-60 (n=2940) 
completed a survey and were invited to participate in an overnight polysomnography 
(PSG) protocol (n= 1522) and were followed for several years (mean = 13.8 years, range 
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1.5-18.7). An eighteen-year follow-up finds that all-cause mortality risk increased 
significantly with SDB severity (Young et al., 2008). The adjusted hazard ratio (95% CI) 
for SDB vs no SDB was 3.0 (1.4, 6.3). Individuals with severe SDB had a hazard ratio 
(95% CI) of 5.9 (2.6, 13.3). Having SDB, especially unrecognized or untreated, 
significantly increases mortality. This study has slightly more male participants (55%), 
the first exclusion criteria is pregnancy, and the enrollment of subjects 30-60 years of age 
covers only a fraction of a woman’s reproductive period. The study is important in 
establishing that SDB has a significant impact on cardiovascular events and life 
expectancy. It also emphasizes the need to clinically recognize and treat SDB regardless 
of age, sex, or BMI. By not screening, diagnosing, and treating this problem we are 
putting patients at risk. The second point to be made about this study is younger women, 
especially pregnant women were not included as part of the study population and there is 
a growing body of knowledge that indicates they are at risk for SDB, higher mortality 
during pregnancy, and later in life. 
 Both of these studies focused on the influence of SDB on cardiovascular events 
such as hypertension and myocardial infarction with the result being a strong association. 
In addition, these studies demonstrate the direction SDB research has been moving: older 
adults and mostly men. Both studies are the bedrock of research into SDB and have been 
instrumental in guiding subsequent research. Unfortunately, the majority of research has 
been focused on studying the older, predominately male. Women of reproductive age are 





Pregnancy is a time of almost unprecedented change in a woman’s life. When 
viewed through the lens of nursing science (person, environment, health, and illness) all 
aspects undergo significant alterations in a relatively short amount of time. The physical 
and physiologic changes produce a wide range of symptoms that occur throughout the 
pregnancy and can vary from day to day. Symptoms can range from the obvious, such as 
an increase in physical size to an insidious rise in blood pressure. Multiple symptoms 
may be present at any time and arise from multiple conditions. As a woman experiences 
symptoms she must perceive, evaluate, and manage the symptom appropriately. 
 Symptom Management Theory (SMT) was used to guide the study (Humphries et 
al., 2008).  There are three essential concepts that comprise SMT: symptom experience, 
symptom management strategies, and symptom status outcomes. Symptom experience is 
the simultaneous perception, evaluation, and response to a change in how one usually 
feels. Symptom management is the effort to avert, delay, or minimize the symptom 
experience. Symptom status outcomes are measures of how effective the symptom 
management was at decreasing the perceived symptom (Humphries et al., 2008). 
The symptom management model is based on six assumptions. (Dodd et al., 
2001) First, the perception of the individual experiencing the symptom is the gold 
standard for the study of symptoms. The symptom does not have to be experienced by an 
individual to apply the model. The individual may be at risk for the development of the 
symptom and require a plan to manage the symptom at some point in the future. Non-
verbal patients may experience symptoms with a caregiver interpreting the symptom for 
the purpose of intervening. The management strategy may be targeted at multiple levels 
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from the individual to groups or a work environment. Symptom management is a 
dynamic process that is modified based on individual outcomes and the influences of 
healthcare providers, the environment, and health/illness domains. Three of these 
assumptions are especially important for this study. The risk for developing a symptom 
(snoring, sleepiness) based on a context variable (pregnancy) directly applies. A woman 
at the beginning of pregnancy may not have any symptoms of changing health or illness 
but as the pregnancy progresses symptoms are bound to appear. Symptom management is 
a dynamic process with constant perception, evaluation and response and is ideally suited 
to the steady onset of change during pregnancy. As the fetus grows and develops, 
physiology, psychology and social changes all take place. The management strategy may 
include the participant’s spouse or bed partner, changes to the work environment, and 
support of family members. 
As mentioned previously, there are a number of symptoms of pregnancy. Specific 
to SDB, snoring and daytime sleepiness are symptoms that may develop at any time and 
worsen throughout the pregnancy. These symptoms may present a challenge to manage. 
Snoring may not be noted if a woman lacks a sleep partner or may be perceived as a sign 
of deep sleep– a confusing result when experiencing excessive daytime sleepiness. 
Arousal and sleep fragmentation may result from SDB but be associated with other 
physical discomforts and an inability to enter a restful state. Cultural expectations of 
fatigue during pregnancy may mask an underlying physiologic cause. The use of SMT 
guides the patient and provider to explore the symptoms of snoring and excessive 
daytime sleepiness, screen and test for SDB, explore options to manage the symptoms 
(minimize weight gain, airway support therapies), and assess management progress with 
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testing (at home sleep study).  Through identification and management of the symptoms 
of SDB definitive action can be taken to minimize or alleviate the impact of SDB on the 





Figure 1.  Model of Symptom Management Theory 
Prevalence 
The prevalence of OSA in the pregnant population is not known and determining 
that number is complicated due to a lack of a validated screening instrument. Using data 
from the Wisconsin Sleep Cohort Study, Young et al. (1993) were able to demonstrate 
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2% of women and 4% of men in the middle-aged workforce meet minimum diagnostic 
criteria for sleep apnea syndrome. The prevalence of SDB was significantly higher in 
men, in all age groups, and at three AHI cut points of ≥ 5, ≥ 10, and ≥ 15 with men 2.0-
3.7 times more likely than women to have SDB. The study population was a random 
sample of Wisconsin state employees who were selected to be more likely to have SDB 
based on a six question survey.  The age for inclusion was a minimum of 30 years and the 
first exclusion criteria was pregnancy. This is an ongoing community-based study and a 
recent follow-up analysis found that the prevalence of SDB continues to rise at 
substantial rates across all subgroups over the past two decades. (Peppard et al., 2013) 
Using the Wisconsin Sleep Cohort Study (WSCS) data, Peppard et al (2013) developed 
SDB prevalence models based on age group, sex, and weight status categories for two 
time periods: the early 1990’s and late 2000’s. The prevalence model was then applied to 
data over the same time periods from the National Health and Nutrition Examination 
Survey (NHANES) and compared with the original data from the WSCS. The study 
found that men aged 30-49 had a prevalence estimate of moderate to severe SDB (AHI ≥ 
15) of 10% while women in the same cohort had a prevalence of just 3%. As both groups 
increased in age the prevalence increased. For men aged 50-70 the prevalence estimate of 
moderate to severe SDB (AHI ≥ 15) was 17% and for women it was 9%. Based on this 
information, women have roughly half the risk of developing OSA as men. However, the 
study may have missed the greatest period of exposure for the development of SDB/OSA 
and the associated morbidities-pregnancy.  
The majority of studies of SDB in pregnancy have focused on the sub-set of the 
obstetric population at greatest risk: patients with obesity, diabetes, and hypertensive 
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disorders. Louis et al. (2012) investigated perinatal outcomes in obese pregnant women 
with and without OSA and reported a prevalence of 15.4% (95% CI, 10.4-21.6%).  A 
strength of this study was that the diagnosis of SDB was confirmed by polysomnography. 
Sahin et al. (2008) also investigated pregnancy outcomes related to OSA. From a small 
sample of 35 pregnant women, an OSA prevalence of 11.4%, confirmed by 
polysomnography, was reported. A key factor for both studies is the use of 
polysomnography to confirm the diagnosis of SDB, the gold standard. Polysomnography 
is expensive, cumbersome, and time consuming making it difficult to apply to larger 
studies and further supports the need for less expensive, reliable, and efficient screening 
measures.  
The prevalence of SDB changes throughout pregnancy. Facco et al (2014) 
examined a cohort of 128 pregnant women at high-risk for SDB. (Facco, Ouyang, Zee, & 
Grobman, 2014) Pregnant women with any of the following were recruited: BMI > 30, 
chronic hypertension, pregestational diabetes, history of preeclampsia, and/or a twin 
gestation. At-home overnight sleep studies were conducted between 6-20 weeks gestation 
and again between 28-37 weeks gestation. Sleep disordered breathing was defined as an 
AHI ≥ 5 and categories of mild (AHI 5-14.9), moderate (AHI 15-29.9), and severe (AHI 
≥ 30) were used. Participants that had an initial AHI < 5 at baseline but then had an AHI 
≥ 5 in the third trimester were reported as new onset SDB. The baseline prevalence of 
mild, moderate, and severe SDB was 21%, 6%, and 3%. The third trimester prevalence 
for mild, moderate, and severe was 35%, 7%, and 5%. A new diagnosis of SDB was 
made in 20% of the participants and 27% of participants had increased severity of SDB. 
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Sleep disordered breathing is as dynamic as pregnancy and may develop or increase in 
severity throughout pregnancy. 
In a recent study, Louis et al. (2014) used ICD-9 codes and the Nationwide 
Inpatient Sample (NIS) database to identify Obstructive Sleep Apnea (OSA) in pregnant 
women and evaluate patient outcomes. The study estimated 55 million pregnancy-related 
inpatient discharges were evaluated in the United States over an 11-year period (1998-
2009) from the NIS database were evaluated. During the first year of the study, 1998, the 
prevalence of OSA in the study population was 0.7% per 10,000 population; during the 
last year of the study, 2009, the prevalence rate had increased tenfold to 7.3 per 10,000 
population with an annual average increase of 24.4% (95% CI, 22.1-26.8%) (J. M. Louis 
et al., 2014). The annual average increase correlates strongly with a reported average 
increase in clinically diagnosed obesity rate of 20%. The study results may be affected by 
the general increase in knowledge of SDB and OSA as more research has been conducted 
over the 11-year period. A limitation was that the authors could not confirm if women 
were treated with continuous positive airway pressure therapy. However, the rise in OSA 
prevalence is impressive, especially with the corresponding rate of obesity, and predicts a 
major threat to health that is not being assessed on a regular basis. 
Outcomes 
While the prevalence of SDB varies between studies and populations and is 
hindered by a lack of validated screen for use during pregnancy, there are consistent and 
concerning trends in the outcomes. SDB is associated with chronic hypertension, asthma, 
diabetes mellitus, and depression (J. M. Louis, Auckley, Sokol, & Mercer, 2010). During 
pregnancy, OSA may be associated with preeclampsia, cesarean delivery, preterm birth, 
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and increased morbidity. In a retrospective cohort study of obese and non-obese pregnant 
women with OSA confirmed by polysomnography, Lewis et al. (2012) identified several 
concerns. Women with OSA were more likely to have a primary cesarean delivery for 
arrest of labor when compared with obese controls and normal-weight controls (19% vs. 
10% and 3.5%, respectively; p <.001). Preeclampsia was also more prevalent in the OSA 
group than in the normal weight controls (19.3% vs. 7%, p = .02). Preterm birth (<37 
weeks) was greater in the OSA group than normal weight controls (29.8% vs. 12.3%, p 
=.007).  A composite morbidity factor was also evaluated as an outcome measure. The 
composite factor was defined as a patient having one or more of the following: blood 
transfusion, conversion from regional to general anesthesia, unexpected surgical 
procedure (excluding cesarean section), postpartum endometritis, maternal sepsis, 
pneumonia, wound complications, prolonged post-delivery hospital stay (≥ 3 days for 
vaginal delivery, ≥ 5 days for cesarean delivery), intensive care unit admission, and/or 
hospital readmission. Subjects with OSA had greater morbidity (OR 4.6, 95% CI 1.5-
13.7) than those without. This study is unique in that all cases of OSA were confirmed by 
polysomnography and matched controls of both obese and normal weight participants 
were used. This study underscores the relationships between obesity, OSA, and comorbid 
conditions.  
Another study focusing specifically on snoring during pregnancy and delivery 
outcomes reported women with SDB were at greater risk for emergency cesarean 
delivery and small-for-gestational age. Obrien et al. (2013) studied 1,673 pregnant 
women ≥ 18 years of age and ≥ 28 weeks pregnant to determine the effect of maternal 
snoring on delivery outcomes. The study found an independent association between 
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chronic, pre-pregnancy snoring and <10th birth centile (OR 1.65, 95%CI 1.02-2.66, 
p=0.041). Chronic and pregnancy onset snoring are independently associated with 
elective cesarean delivery (OR 2.25, 95% CI 1.22-4.18, p=0.006 and OR 1.70, 95% CI 
1.13-2.57, p =0.012). In a separate analysis that controlled confounding variables such as 
presence of preeclampsia and gestational diabetes, maternal education, induction of labor, 
and birth centile pregnancy onset snoring was independently associated with emergency 
cesarean delivery (OR 1.68, 95% CI 1.22-2.30, p=0.001).  
With more operative deliveries and more emergent operative deliveries a rise in 
morbidity can be expected but the underlying cause needs to be evaluated, especially if it 
is preventable. Emergent operative deliveries and intensive care for infants of low birth 
weight or small-for-gestational-age is extremely expensive. A wide range of 
complications from surgery may occur and can range from the mundane to life 
threatening. If a facility is unprepared or lacks adequate resources to manage a maternal 
or neonatal complication related to SDB the result may be catastrophic.  
During labor and delivery, OSA also has been linked with outcomes that have 
specific anesthesia implications. A study evaluating sleep in the five nights prior to 
delivery and early labor found women with less total sleep time (TST) the night before 
birth had higher total pain scores during labor (Beebe & Lee, 2007). Sleep deprivation 
may impact the ability to tolerate labor pain and could change the timing and duration of 
epidural pain management 
Another unique study of OSA and pregnancy outcome is from Lee and Gay 
(2004). A prospective observational study of 131 women during the ninth month of 
pregnancy used actigraphy and questionnaires to determine the effect of sleep and fatigue 
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on labor duration and delivery type. Participants wore a wrist actigraph to determine total 
sleep time (TST) and wake after sleep onset (WASO)–an estimate of sleep disruption. 
Women with sleep disruption (WASO ≥ 15%) were 5.2 times more likely to have 
cesarean delivery. Women with a total sleep average of less than 6 hours of sleep per 
night were 4.5 times more likely to have a cesarean delivery than women who averaged 7 
hours of sleep. Labor duration was also studied but relied on self-report of labor duration 
rather than confirmation by vaginal exam. This study proposes a prescription for an 
amount of sleep (at least 8 hours) during pregnancy and draws on the analogy of other 
habits during pregnancy. In addition to “eating for two” pregnant women should also 
consider “sleeping for two” and should be getting a minimum of 8 hours of sleep each 
night. 
One of the most dramatic outcomes in the association between OSA and maternal 
mortality comes from Louis et al. (2014). In a study using an estimated 55 million 
records from the National Inpatient Sample over an 11-year period, women with OSA 
had a approximately five-fold higher odds of dying prior to discharge than women 
without OSA even after adjusting for comorbidities such as cardiovascular, renal, and 
metabolic conditions (J. M. Louis et al., 2014). A risk this great demands action.  
Obesity 
Obesity is perhaps the strongest correlate with OSA across all populations. Excess 
body weight and fat accumulation can work in several ways to develop OSA. Fat 
accumulation can alter upper airway structure, increase total body oxygen demand, and 
decrease functional residual capacity–all of which can promote or exacerbate OSA 
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(Young et al., 2002). Excess weight gain before or during pregnancy in excess of Institute 
of Medicine recommendations is also an independent predictor of preeclampsia.  
Obesity is a significant confounding variable in the study of OSA. Excess weight 
gain is thought to play a role in the development and progression of OSA. The overall 
trend in the United States is an increase in the number of individuals who can be 
classified as overweight or obese. A recent study found the incidence of obesity (BMI > 
30) among adult women over 20 years of age in the U.S. is 35.8% (95% CI, 34.0-37.7%)  
(Flegal, Carroll, Kit, & Ogden, 2012). When overweight (BMI > 25%) is included the 
number jumps to 63.7% (95% CI, 60.9%-66.4%)  (Flegal et al., 2012). Being overweight 
during pregnancy increases the risk for several co-morbidities that have specific 
cardiovascular implications for the nurse anesthetist. A large study in Denmark found 
that as BMI increased above 25% the risk of co-morbid conditions and complications 
increased. Notably, of all births in Denmark from January 1, 2004 through June 30, 2010, 
Ovesen et al. (2011) found as BMI increased from overweight, obese, and severely obese 
the odds ratios for diabetes, preeclampsia, and cesarean delivery also increased 
significantly. Specifically for preeclampsia, the odds ratios were 1.9, 3, and 4.4 for the 
three BMI groups. Because of the relationship between obesity and OSA, studies have 
focused on the obese pregnant population. Louis et al. (2012) investigated outcomes of 
175 obese gravid women and found OSA prevalence of 15.4% that was confirmed 
through PSG. The authors noted the group diagnosed with OSA had a higher mean BMI 
(46.8 ± 12.2 compared with 38.1 ± 7.5; p =.002), was more likely to be diagnosed with 
asthma (48.1% compared to 22.9%, p =.007), and chronic hypertension (55.6% compared 




The link between SDB and hypertensive disorders during pregnancy is becoming 
more evident. O’Brien et al. (2012) conducted a prospective cohort study for pregnancy-
onset habitual snoring, gestational hypertension, and preeclampsia. Women were 
recruited during their third trimester of pregnancy and compared to a non-pregnant 
control group. This study chose to examine the presence of habitual snoring instead of 
using a multi-item sleep disordered breathing questionnaire. The authors argue no study 
has failed to associate snoring with objective measures of SDB obtained from 
polysomnography and validation of SDB screening tools have not been performed on 
pregnant subjects. The study reports pregnant women were more than twice as likely to 
snore than the non-pregnant control group (34.1% vs. 14.9%, p < .0001). Through a 
logistic regression that controlled for covariates, pregnancy-onset snoring was 
independently associated with gestational hypertension (OR, 2.36; 95% CI, 1.48-3.77; p 
< .001) and preeclampsia (OR, 1.59; 95% CI, 1.06-2.37; p = .024). This study is 
important as the first to prospectively, in a large population, report significant risk to 
maternal cardiovascular health from pregnancy-onset snoring. 
These studies have focused on a sub-set of the obstetric population deemed to be 
at high-risk for SDB and have not included the general obstetric population. While 
obesity, diabetes, and hypertension have strong correlations with SDB, they have not 
been shown as causative and it is possible to have SDB without any of these co-




The Berlin questionnaire is widely used to screen for SDB/OSA and was 
originally validated in the primary care setting, but has since been used in the surgical 
population with moderately high sensitivity (68.9), specificity (56.4), positive predictive 
value (77.9) and negative predictive value (44.9) (Chung & Elsaid, 2009). The Berlin 
questionnaire consists of 11 items comprising three categories: snoring, daytime 
sleepiness, and hypertension. The scoring of the instrument is cumbersome. Items have 
multiple responses and are assigned a point value which is added with other items in the 
category to create a category score that will either be “positive” or “negative.” If two of 
the three categories are positive, the participant is at high risk for OSA. Reports of 
sensitivity for the Berlin Questionnaire range from 54% to 86% with specificity from 
43% to 87% in a primary care setting. In the surgical population, the Berlin Questionnaire 
has been compared alongside the STOP Questionnaire and the American Society of 
Anesthesiologists (ASA) checklist. The sensitivity and specificity of the Berlin 
questionnaire varies depending upon the level of the apnea-hypopnea index (AHI) used 
and the population under study. In addition, the Berlin questionnaire has been used in 
pregnant populations (Sahin et al., 2008). 
STOP-Bang (SB) is a model derived from the Berlin questionnaire and used 
extensively in anesthesia. Initially, SB was created as a condensed, four item version of 
the Berlin questionnaire for the surgical population that was easier to administer and 
score (Chung et al., 2008a). SB was later created to gain greater sensitivity and 
specificity. STOP-Bang consists of eight items: S-snoring, T-tired or fatigued, O-
observed apnea, P-pressure (high blood pressure), B-body mass index (BMI),  
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A-age, N-neck circumference, and G-gender. STOP-Bang has a sensitivity of 83.6%, 
92.9%, and 100% for the AHI cutoff scores of 5, 15, and 30 respectively. The test re-test 
reliability was found to be 96.4% with a kappa coefficient of 0.923 (CI, 0.82-1.00). For 
validity, the STOP questionnaire was compared against a one-night-in-laboratory PSG 
study with a calculated apnea-hypopnea index (AHI) scored by a sleep physician using 
American Academy of Sleep Medicine practice guidelines. The guidelines classify 
severity as: mild (AHI 5-14), moderate (AHI 15-29), severe (AHI >30). Both STOP and 
STOP-Bang models were assessed for sensitivity at the guideline levels. STOP has 
sensitivities of 65.6% for AHI > 5, 74.3% for AHI > 15, and 79.5% for AHI > 30. The 
alternative scoring model STOP-Bang had significantly increased sensitivities of 83.6 % 
AHI ≥ 5, 92.9 % for AHI ≥ 15, and 100 % for AHI ≥ 30. Each item is a forced choice 
yes/no question with basic measurements and simple calculations and can easily be 
scored. Answering “yes” to three or more items indicates a high risk for OSA, answering 
“yes” to less than three items is a low risk for OSA. The instrument can be completed in a 
relatively short period of time and provides a simple endpoint of risk assessment for 
OSA. Tantrakul et al (2015) recently validated the STOP-Bang in an obstetric population. 
(Tantrakul et al., 2015) Pregnant women from a high-risk pregnancy clinic were recruited 
to undergo sleep evaluations utilizing the Berlin and STOP-Bang questionnaires and at-
home overnight sleep studies. Of the 72 women recruited, 23 were in the first trimester, 
24 in the second trimester, and 25 were in the third trimester. The prevalence of OSA by 
trimester was 30.4% in the first, 33.33% in the second, and 32.0% in the third trimester 
and was confirmed by sleep study. The sensitivity across the trimesters was 57.1% in the 
first, 62.5% in the second, and 62.5% for the third. The specificity was 87.5% for the 
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first, 93.8% for the second, and 88.2% for the third trimester. These values indicate a 
limited utility for STOP-Bang in the first trimester but acceptable results for use in the 
second and third trimester.  
A Four-Variable Model (FFV) has been proposed specifically for use in the 
pregnant population. Facco et al. (2012) set out to develop a screening algorithm using 
the most sensitive indicators from the Berlin and ESS questionnaires by conducting a 
multivariable logistic regression. While both Berlin and ESS performed poorly, four 
variables overall were found to be independent significant factors in the identification of 
OSA in high-risk pregnant women: self-reported snoring, chronic hypertension, pre-
pregnancy BMI, and age. To score this assessment, the age is added to the BMI and if 
snoring ≥3 times per week is noted, 15 points are added. If chronic hypertension is noted, 
another 15 points is added. A combined score for all four variables  ≥75 indicates SDB 
with a sensitivity of 86% (95% CI, 66%, 95%) and a specificity of 74% (95% CI, 62%, 
83%) while being validated in the pregnant population (Facco, Ouyang, Zee, & Grobman, 
2012). This study points out while pregnant, daytime sleepiness is not specific to OSA 
but is quite common throughout pregnancy. Neither ESS or Berlin includes age in the 
assessment and the Berlin uses BMI ≥ 30 as a categorical variable where there may be a 
more direct and linear relationship between OSA and BMI.  
Anesthesia, OSA, and Pregnancy 
Unlike the obstetrician who may have the benefit of establishing a relationship 
and monitoring co-morbidities over the duration of the pregnancy, the anesthetist may 
only meet the patient a few hours before delivery. Obstructive sleep apnea is associated 
with obesity, preeclampsia, diabetes, difficult intubation, cesarean delivery, and 
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sensitivity to anesthetic agents, sedatives and hypnotics–all of which can complicate 
anesthetic care. In the immediate setting of providing anesthesia for a cesarean section, 
perhaps the only modifiable risk factor is the anesthetic and the use of neuraxial narotics. 
Preservative-free morphine has been approved for neuraxial administration for 
post-operative analgesia since 1984 and has been used extensively (Sultan, Gutierrez, & 
Carvalho, 2011). There is the potential adverse effect of respiratory depression that is 
significantly concerning. The pharmacokinetics of opioids can be complex, especially 
when comparing interactions or differences between compartments such as spinal or 
epidural and plasma. Epidural pharmacokinetics are especially challenging as they may 
vary by level of insertion (Sultan et al., 2011). The incidence of respiratory depression 
from neuraxal administration of preservative-free morphine is difficult to ascertain. Kato 
et al. (2008) conducted a retrospective review of 1,915 cesarean section cases that used a 
standard dose of 0.15 mg intrathecal morphine. Of the study population, only five women 
(0.26%) developed bradypnea (respiratory rate ≤ 10 breaths/min) and only one required 
naloxone (0.052%). The study has key limitations that prevent application to broader 
populations. The authors did not report a mean BMI for the study population and only 
patient number five of the bradypnea group was reported to have an elevated BMI of 34.7 
kg/m2. The study took place in Japan which may have a different rate of obesity than the 
United States. A confounding variable, additional pain medication use during the study 
period, was not reported and there was no investigation of sleep apnea or other co-
morbidities. A more relevant study to the US population that does account for obesity 
was recently conducted. Crowgey et al. (2013) used a retrospective study of 5,036 
postcesarean patients with a mean BMI = 34 kg/m2 who all received neuraxial morphine. 
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The rate of obesity is impressive with 63% having a BMI ≥ 30 kg/m2. The anesthetic 
dose and route were monitored with 3,554 patients receiving spinal morphine doses 
ranging from 0.05 to 0.25 mg (90.4 % received 0.15 mg) and 1,080 patients receiving 
epidural doses ranging from 1 to 5 mg (92.9% received 3 mg).  The records were 
reviewed to determine if naloxone was given to reverse respiratory depression or if the 
Rapid Response Team (RRT) was activated to respond to the respiratory depression. 
Despite the large sample size and prevalence of obesity, not a single patient was 
identified as requiring naloxone treatment or rapid response team involvement for 
respiratory depression. A significant limitation is the study does not account for minor 
incidents of hypoventilation or desaturation primarily because respiratory monitoring was 
intermittent. In addition, there was no investigation into co-morbid factors such as sleep 
apnea. Both of these studies show a lack of respiratory depression in what should be an 
at-risk population–especially with a high rate of obesity.    
Screening for OSA may provide additional information to the nurse anesthetist 
that might be used to alter the anesthetic plan. A provider may make extra preparations to 
prepare for a difficult airway knowing there is a high likelihood for OSA. Epidural pain 
management may be initiated earlier or a tenuous epidural replaced based on the 
knowledge of an increased cesarean delivery rate with OSA. Narcotic dosing with spinal 
anesthetics may be decreased or eliminated based on concerns for increased OSA after 
surgery and a need for additional monitoring. Alternative pain management plans such as 
non-narcotic pain medications and regional anesthesia such as transverse abdominal 
plane blocks may be used. If general anesthesia is required, knowledge of OSA can affect 
decisions about when to extubate. Resources for both mother and child may not be 
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sufficient and a transfer of care may be required to a facility with a neonatal intensive 
care unit (NICU) and continuous monitoring capability. Not knowing about a condition 
like OSA that interacts with so many crucial aspects of anesthesia may be the most 
dangerous situation of all.  
Future Research 
Many screening tools currently in use have been designed for sleep clinics or 
primary care settings and may measure single attributes of SDB, such as sleepiness, but 
not be of predictive value for SDB. Research shows pregnant women are at significant 
risk of poor outcomes with tremendous cost to the patients and the healthcare system. 
Sleep clinics and labs are already struggling to accommodate the increased awareness of 
OSA in the general population and struggling to meet the need for screening. Pregnant 
patients may choose not participate in overnight, in-lab PSG studies. Pregnancy, 
especially late into the third trimester, is notorious for poor sleep even in the routine 
conditions of home. Reporting to a hospital for an overnight study may be inconvenient 
in accommodations have to be made for the care of children at home. While the risk of 
respiratory depression after neuraxial narcotics may be low, the consequence may be 
fatal. A nurse anesthetist in the busy perioperative setting can not change many of the risk 
factors and co-morbid conditions but must adapt an anesthetic plan that best fits the 
patient’s condition. Not knowing about the presence and severity of a condition like SDB 
is a significant risk. Awareness of the prevalence of SDB at the time of delivery can help 
in the allocation of resources and staffing. A screen that is simple, reliable, and valid for 
the pregnant population could greatly improve the outcomes of a growing number of 





The purpose of this study was to examine the prevalence of Sleep Disordered 
Breathing (SDB) and its association with perinatal complications in pregnant women at 
delivery using the Facco Four Variable model and the STOP-Bang score at a large 
Military Treatment Facility (MTF).  In this chapter information on how the study was 
conducted is provided and includes the study aims, the research design, the sample and 
sampling, data collection procedures, and analysis plan.  A discussion of protection of 
human subjects is also provided.  
Specific Aims: 
     Aim I.  To examine the prevalence of SDB using a cut-score of ≥75 on the Facco 
Four Variable model and a score ≥ 3 on the STOP-Bang model in a general 
obstetric population admitted in the immediate postpartum period at a large 
academic Military Treatment Facility. 
    Aim 2:  To examine if parturients suspected of having SDB as assessed by the 
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB; 
score ≥ 3) have higher rates of the following adverse maternal child 
outcomes: gestational hypertension, low birth weight <2500 gms, NICU 
admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia, 
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite 
score of adverse pregnancy outcomes, and a composite score of 
cardiopulmonary complications that includes pulmonary embolism, in-
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hospital mortality, pulmonary edema, congestive heart failure, and 
cardiomyopathy. 
Aim 3. Compare the prevalence rates of suspected SDB at delivery between active 
duty and non-active duty parturients.  
Design 
This study used a prospective, cross-sectional, observational design utilizing the 
Facco Four Variable (FFV) model and STOP-Bang model to examine the prevalence of 
SDB in the third trimester, pregnant population at a large military treatment facility. 
Sample and Sampling  
The setting for this research was the post-partum wards of a tertiary care military medical 
center and teaching hospital in the southwestern United States. The primary source for 
data collection was from the main postpartum wards. The MTF averages more than 300 
deliveries a month including high-risk and complicated OB patients. There is a dedicated 
in-house obstetric anesthesia team supporting 10 labor, delivery, recovery, postpartum 
(LDRP) suites 24 hours a day. Participants enrolled were geographically limited to 
Southern California and the greater San Diego area. 
Sample Size Estimation 
The primary aim of this study was to examine the prevalence of SDB using a cut-
score of ≥75 on the Facco Four Variable model and a score ≥ 3 on the STOP-Bang model 
in a general obstetrical population in the immediate postpartum period at a large 
academic Military Treatment Facility. Previous research suggest between 16.4 - 26.7% of 
parturients considered to be at high-risk for SDB at term have symptoms and/or 
confirmed SDB (Facco et al., 2012 and Pien et al., 2014). We estimated 20% of our 
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patients may have symptoms of SDB at term. To estimate the sample size for a 
descriptive study of a dichotomous variable, a sample size estimating table from Hulley 
et al. (2007) was used. The expected proportion of our sample to screen positive for SDB 
was 20%. With an estimated proportion of 0.20 positive for SDB, a 95% confidence 
interval with a total width of 0.10 (0.05 below and 0.05 above), using table 6E our 
estimated sample size was 246 participants. To account for attrition a total sample of 300 
participants were recruited. The population at the site of the study was unique in that 
active duty military and dependents all have access to the same high-quality health care. 
None of the participants were uninsured or lacking resources for health care. 
Additionally, the active duty subjects are required to maintain strict standards for body 
composition and exercise performance. In theory, the active duty participants were in 
good health. These two components made it difficult to estimate a prevalence of SDB and 
adverse pregnancy outcomes for the study.  
For the second aim, to examine if parturients suspected of having SDB as 
assessed by the Facco Four Variable Model (score ≥75) and STOP-Bang (score ≥ 3) have 
higher rates of the adverse pregnancy outcomes (gestational hypertension, 
preeclampsia/eclampsia, gestational diabetes, non-elective cesarean delivery, NICU 
admission, low birth weight <2500 gms, preterm delivery <37 weeks, a composite score 
of adverse pregnancy outcomes, and a composite score of cardiopulmonary 
complications (pulmonary embolism, in-hospital mortality, hospital stay >5 days, 
pulmonary edema, congestive heart failure, cardiomyopathy). An analysis was conducted 
after enrolling the first 300 participants. As previously stated, disparity between initial 
prevalence estimates of outcome data resulted in a reassessment of sample size and study 
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feasibility. Based on concerns for time, resources, and feasibility recruitment was halted 
after an analysis of the initial 300 participants was concluded. 
Data Collection Procedures 
Patients in the third trimester of pregnancy were asked if they would like to 
participate in the study “Sleep Disordered Breathing in Pregnancy.” The PI approached 
the patient about her potential enrollment in the study if she was in the third trimester of 
pregnancy and met the inclusion criteria with no conditions from the exclusion criteria. 
Inclusion criterion: any woman eligible for care at MTF presenting for delivery in the 
third trimester. Exclusion criteria were limited to any patient not wishing to participate in 
the study, not eligible for care at MTF, not admitted for delivery, and any patient 
admitted for fetal demise.  The patient could refuse to participate at any time and 
withdraw from the study without any retribution. Written informed consent was obtained, 
baseline demographic data collected, and the Facco Four Variable and STOP-Bang 
models were completed. This concluded Phase I of data collection. The participant was 
told she could refuse to participate at any time and withdraw from the study at any time 
without any retribution. The second phase of data collection commenced after the 
participant completed the baseline study data. The electronic medical record was 
reviewed after birth and data regarding the study outcome variables collected and entered 
into the study database. This concluded the second phase of data collection. 
Instrumentation 
Facco Four Variable (FFV) Model.  The gold standard for evaluating and 
diagnosing OSA is an in-laboratory, overnight polysomnogram. Unfortunately, this test is 
cumbersome, expensive, and time consuming. Alternative methods for screening and 
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evaluating for obstructive sleep apnea have been developed, but very few have been 
studied in the pregnant population. The Berlin questionnaire (Netzer et al., 1999) and the 
Epworth Sleepiness Scale (ESS) (Johns, 1991) are instruments used to screen for sleep 
disordered breathing and have both been tested in pregnant populations. The Berlin 
questionnaire and the ESS were used to develop a four variable, pregnancy specific, SDB 
screening model used in this study.   
The Berlin questionnaire (Netzer et al., 1999) is perhaps the most widely used 
screener for OSA and was originally validated in the primary care setting, but has since 
been used in the surgical population with moderately high sensitivity (68.9), specificity 
(56.4), positive predictive value (77.9), and negative predictive value (44.9).19 The 
Berlin questionnaire consists of 11 items comprising three categories: snoring, daytime 
sleepiness, and hypertension. The scoring of the instrument is cumbersome. Items have 
multiple responses and are assigned a point value which is added with other items in the 
category to create a category score that will either be “positive” or “negative.” If two of 
the three categories are positive, the participant is at high risk for OSA. Reports of 
sensitivity for the Berlin questionnaire range from 54% to 86% with specificity from 43% 
to 87% in a primary care setting. The sensitivity and specificity of the Berlin 
questionnaire varies depending upon the level of the apnea-hypopnea index (AHI) used 
and the population under study. The Berlin questionnaire has been used in pregnant 
populations. (Sahin et al., 2008) 
From the Berlin questionnaire and the ESS, Facco and colleagues (2012) 
developed a four variable model to screen for SDB during pregnancy. The Berlin and 
ESS questionnaires were administered to 114 parturients at high-risk for SDB. The study 
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participants also underwent an at-home overnight sleep study. An item analysis was 
conducted to determine which items from each questionnaire were of greatest value in 
accurately identifying a woman as having SDB. Demographic, clinical, and subjective 
symptoms associated with SDB through univariable analysis were included as covariates 
in a multivariable logistic regression model with the items from the Berlin and ESS 
questionnaires. The result of the analysis is the four variable model: pre-pregnancy BMI, 
age, chronic hypertension, and frequent snoring were independent significant risk factors 
for SDB. The model consists of a score for these four variables to calculate a total score. 
The subject receives 15 points for frequent snoring (≥ 3 times per week) and another 15 
points if they report chronic hypertension. This sum is added to the summation of their 
age (years) and BMI. If the total score is ≥75, the model predicts, in a high-risk group, 
the diagnosis of OSA with a sensitivity of 85.7% (66.4%, 95.3%) and specificity of 
73.6% (61.7%, 83.0%) (Facco et al., 2012). 
STOP-Bang (SB) Model 
STOP-Bang is a model also derived from the Berlin questionnaire. STOP-Bang 
consists of eight items: S-snoring, T-tired or fatigued, O-observed apnea, P-pressure 
(high blood pressure), B-body mass index >35 (BMI), A-age, N-neck circumference >40 
cm, G-gender (Chung et al., 2008b). SB has a sensitivity of 83.6%, 92.9% and 100% for 
the AHI cutoff scores of 5, 15, and 30 respectively. The test re-test reliability was found 
to be 96.4% with a kappa coefficient of 0.923 (CI, 0.82-1.00). For validity, the STOP 
questionnaire was compared against a one-night-in-laboratory PSG study with a 
calculated apnea-hypopnea index (AHI) scored by a sleep physician using American 
Academy of Sleep Medicine practice guidelines. The guidelines classify AHI severity as: 
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mild AHI 5-15, 15-30 moderate, greater than 30, severe. STOP-Bang model was assessed 
at the guideline levels with sensitivities of 83.6 % AHI > 5, 92.9 % for AHI > 15, and 
100 % for AHI > 30. Each item is a forced choice yes/no question with basic 
measurements, simple calculations, and easy scoring. Answering “yes” to three or more 
items indicates a high risk for OSA, answering “yes” to less than three items is a low risk 
for OSA. The instrument can be completed in a relatively short period of time and 
provides a simple endpoint of risk assessment for OSA. STOP-Bang was developed for 
use in sleep clinics, but has been evaluated during pregnancy.  A recent study compared 
SB with the Berlin questionnaire in each trimester of pregnancy in women recruited from 
a high-risk antenatal clinic in Thailand (Tantrakul et al., 2015).  A total of 72 women (23 
first trimester, 24 second trimester, 25 third trimester) were recruited, completed both the 
Berlin and SB questionnaires, and then given an at-home, wrist worn, overnight sleep 
study.  The authors used a unique cutoff point of BMI >27.5 for SB that was determined 
to be culturally specific for their sample. The study found the ability of SB to recognize 
OSA was poor in the first trimester (sensitivity = 57.1%, specificity = 87.5%, PPV = 
66.7%, NPV = 82.7%, AUC 0.71, p = 0.23, CI 95% = 0.47-0.92), improved in the second 
trimester (sensitivity = 62.5%, specificity = 93.8%, PPV = 83.3%, NPV = 83.3%, AUC 
0.78, p = 0.23, CI 95% = 0.47-0.92), then decreased in the third trimester (sensitivity = 
62.5%, specificity = 88.2%, PPV = 71.4%, NPV = 83.3%, AUC 0.75, p = 0.04, CI 95% = 
0.53-0.97). 
Outcome Data 
 Maternal Outcome data for this study was based on a review of the literature 
and comes from studies that have focused on women at high risk for developing SDB 
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(obesity, diabetes, hypertensive disorders). Obesity figures prominently in SDB and 
multiple measures of body weight and body mass index was assessed. Due to the 
association of SDB with hypertensive disorders in the general population, diagnosis of 
hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, chronic 
hypertension) were recorded from the electronic medical record along with any incidence 
of pulmonary edema, congestive heart failure, or cardiomyopathy as a composite 
variable of cardiopulmonary complications. Cesarean delivery has been associated 
with obesity in the literature therefore SDB therefore delivery method (vaginal vs. 
cesarean) was collected.  
Infant Outcome data included low birth weight (<2500 gms), NICU admission, and 
gestational age. 
Statistical Analysis Plan 
Aim 1: To examine the prevalence of SDB at time of delivery using the Facco Four 
Variable Model and the STOP-Bang model in a general, third trimester, obstetric 
population who deliver at a large Military Treatment Facility (MTF). 
Aim 1 Analysis Plan: To examine the prevalence of SDB, a sample of 300 patients was 
collected. Descriptive statistics were used to calculate the frequency and prevalence of 
SDB as indicated by a score ≥75 on the Facco Four Variable model and a STOP-Bang 
score ≥ 3. Percentages and frequencies were used to describe the results.  
    Aim 2:  To examine if parturients suspected of having SDB as assessed by the 
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB; 
score ≥ 3) have higher rates of the following adverse maternal child 
outcomes: gestational hypertension, low birth weight <2500 gms, NICU 
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admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia, 
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite 
score of adverse pregnancy outcomes, and a composite score of 
cardiopulmonary complications that includes pulmonary embolism, in-
hospital mortality, pulmonary edema, congestive heart failure, and 
cardiomyopathy. 
Aim 2 Analysis Plan: The outcome variables (gestational hypertension, low birth weight, 
preeclampsia, gestational diabetes, cesarean delivery, hospital stay > 5 days, and a 
composite variable of adverse pregnancy outcomes) and the diagnosis of SDB based on a 
score ≥75 on the Facco Four Variable Model and a score of ≥ 3 for the STOP-Bang 
model were dichotomized. Continuous variables such as age, weight (prepregnancy and 
at delivery), BMI (prepregnancy and at delivery), neck circumference, gestational age, 
and length of stay were assessed by t-test.  Fisher’s Exact test was used for dichotomous 
variables such as prepregnancy BMI >30, primigravid status, pregestational diabetes, 
previous cesarean delivery, prior preeclampsia, NICU admission, preterm delivery <37 
weeks, low birth weight <2500 gms, and chronic hypertension. Next, logistic regression 
was used to examine the risk of adverse pregnancy outcomes (gestational hypertension, 
preeclampsia/eclampsia, gestational diabetes, cesarean delivery, NICU admission, low 
birth weight <2500 gms, preterm delivery <37 weeks, a composite of adverse pregnancy 
outcomes, and a composite score of cardiopulmonary complications (pulmonary 
embolism, in-hospital mortality, hospital stay >5 days, pulmonary edema, congestive 
heart failure, cardiomyopathy) in patients with and without SDB. Within our model we 
adjusted for several maternal characteristics and other covariates (active duty status, 
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ethnicity, obesity, advanced maternal age, parity, twin gestation). Adjusted and 
unadjusted odds ratios (OR) with the 95% confidence interval were calculated.  A p-value 
< 0.05 was considered significant.  
Aim 3-Exploratory: Compare the prevalence rates of suspected SDB at delivery between 
active duty and non-active duty parturients.  
Aim 3 Analysis Plan: Descriptive statistics were used to calculate the frequency and 
prevalence of SDB as indicated by a score ≥75 on the Facco Four Variable model and a 
score of ≥ 3 for the STOP-Bang model in each group. Bivariate descriptive statistics were 
computed to compare active-duty vs. dependent patients with the presence or absence of 
SDB as determined by each instrument. Percentages and odds ratios with 95% confidence 
intervals (95% CI) were used to describe the results.  
Compliance Plan 
 The principal investigator was present in the post-partum wards for the 
recruitment of all participants.   
Statement of Assumptions and Protection of Human Subjects 
 Previous studies have been conducted using similar methods without report of 
harm to the subject. Completion of a questionnaire involves minimal risk to a subject 
who is no greater than risk experienced in everyday life. 
 Fatigue may pose a minimal risk to the subjects while completing the 
demographic data and questionnaire. Subjects were seated while the PI gathered the data 
and the entire process took less than 30 minutes to complete. If fatigue occurred, subjects 
could terminate the session and dis-enroll from the study.  
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 The Principal Investigator is a Naval Officer and Certified Registered Nurse 
Anesthetist (CRNA) and subjects may be enlisted military members, officers of lower or 
higher rank, or have preferences about the use of anesthesia for delivery. The risk of 
coercion or intimidation was addressed by the PI not wearing a military uniform. The 
subjects were vocally instructed their participation was completely voluntary and they 
could dis-enroll at any time without any bearing on the healthcare they receive or their 
military service. 
Confidentiality was maintained through the use of a unique subject identifier 
linked to all gathered data and only the investigators have access to this link. All 
electronic data is stored on a password-protected computer and the computer stored in a 
locked case. All of these measures ensure compliance with HIPAA standards.  
Safety Precautions and Emergency Protocols 
 The study involved minimal risk to the subjects and did not interfere with care 
being rendered for the pregnancy. The interviews were conducted on the hospital grounds 
and standard Navy medical procedure and hospital policy was deemed sufficient for 
immediate management of medical events or injuries.  
Description of the system for Maintenance of Records 
 The sources of data for this study are the demographic information file and case 
report form containing the Facco Four Variable model and STOP-Bang model. All of the 
instruments were coded with the subject identification number. A master coding list was 
kept in a locked file in an assigned office at MFT, accessible only to the investigators.  
No protected health information was on any of the data collection forms or computer 
files. The principal investigator kept the research protocols and consent forms in a locked 
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file in an assigned office at NMCSD in compliance with SECNAVINST 3900.39C and 







The purpose of this study was to examine the prevalence of Sleep Disordered 
Breathing (SDB) and its association with perinatal complications in pregnant women at 
delivery using the Facco Four Variable model and the STOP-Bang score at a large 
Military Treatment Facility (MTF).  In this chapter, study results will be presented 
including sample characteristics and results for each research aim.  
Data were collected from March 24, 2015 through June 17, 2015 on 37 data 
collection days. A total of 320 eligible women were screened on the postpartum wards at 
a tertiary care Military Treatment Facility (MTF) with 302 women (94%) agreeing to 
participate and enroll in the study. A database was created using SPSS Statistical 
Software version 23. After reviewing questionnaires and cleaning the data (excluded twin 
deliveries), data provided by 295 participants were used for the analyses.  
Participant Profile 
Study participants were women eligible for care in the Department of Defense, 
Military Health System and were categorized as either an active duty service member or 
other. Active duty participants comprised 38.5% (n=116) of the total sample. The active 
duty group was 86.5 % Navy, 9% Marine Corps, 1.8% Air Force, and 1.8% Army. 
Enlisted ranks from E2-E8 were represented with the largest portion being E4 with 
25.7%, E5 24.8%, and E3 23.9%. Officer participants were considerably smaller in 
number with only 11 participants (3.8%) whose rank ranged from O1-O4. The sample 
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was diverse with 51.7% White, 16.2% Latina, 14.2% Black, and 17.9% Other included 
Asian, Pacific Islander, Native Hawaiian, and Native American/Alaskan Native.  
 Participants mean age was 27.5 ± 5.27 years with a range of 17-43 years. For 37% 
of the sample, this was their first delivery (primiparous) and mean gestation was 274 days 
±10.03 (39 weeks, 1 day), range 230 days (32 weeks, 6 days) to 292 days (41 weeks, 5 
days). The mean pre-pregnancy weight was 150.68 lbs (68.34 kg) ± 34.10, range 77 lbs. 
(34.9 kg) to 284 lbs. (128.82 kg); a mean weight gain of 33.54 lbs ± 6.62(15.21 kg) range 
a loss of 13 pounds (5.89 kg) to a maximum gain of 76 lbs. (34.47 kg). At delivery, the 
mean weight was 184.42 lbs (83.65 kg) with a range of 105-299 lbs (47.62-135.62 kg). 
For delivery BMI, the mean was 31.26 ±5.27with a range of 20.98-46.82. Neck 
circumference measured at delivery had a mean of 13.98 in ± 2.69 (35.51 cm), range 
10.63 in.-17.72 in (27-45 cm). The mean birth weight was 7 lbs 6 oz ± 534.07 (3351.52 
gm), range 12.69 oz-10 lbs, 5.64 oz (360 gm-4899 gm). The mean length of stay was 3.57 





Demographic and Clinical Characteristics of Study Population (N = 295) 
Characteristic n % M SD Range 
Age (years)  -- --   27.47   5.30 17 - 43 
Race       
White 156 51.7 -- -- -- 
Hispanic   49 16.2 -- -- -- 
Black    43 14.2 -- -- -- 
All Others   54 17.8 -- -- -- 
Military Status      
Active Duty 116 38.3 -- -- -- 
Dependent 184 61.1 -- -- -- 
Body Mass Index (kg/m2)      
Pre-pregnancy  -- --   25.54   5.22 16 - 45 
Delivery -- --   31.26   5.27 21 - 47 
Weight Gain During Pregnancy (kg) -- --   15.19   6.62 -6 - 35 
Gestational Age (days) -- -- 275.19   9.63 230 - 292 
Neck Circumference (cm) -- --   35.51   2.69 27 - 45 
Child’s Birth Weight (g) -- -- 3355.00  534.07  360 - 4899 
Length of Stay at Hospital (days) -- --     3.56   1.02  2 - 10 
Note. M = Mean; SD = Standard Deviation. Some percentages do not add up to 100 because of missing 
data.   
 44 
 
 Comorbidities found in the sample are presented in table 2. Induction of labor 
was noted in 38.6% (n=115) of deliveries, 22.8% (n=69) had a cesarean delivery, and 
6.3% (n=19) delivered prior to term. A pre-pregnancy BMI >30 was noted in 18.7% 
(n=56). Gestational hypertension was found in 9.9% (n=30), preeclampsia in 9.3% 
(n=28), and gestational diabetes in 6% (n=18).  Of the infants, 7.3% (n=22) were 
determined to have low birth weight <2500 grams and 10.9% (n=33) required admission 
to the NICU. 
 
Table 2 
Overall Prevalence of Select Comorbidity (N = 295) 
 Sleep Disordered Breathing 
 Present Absent 
Comorbidity N % n % 
Gestational Hypertension   30 9.9 265 90.1 
Gestational Diabetes   18 6 289 94.0 
Preeclampsia    28   9.3 267 90.7 
Preterm Delivery (< 37 weeks)   19   6.3 276 93.7 
Low Birth Weight (< 2500 g)   22   7.3 273 92.7 
Induction 115 38.6 180  61.4 
Cesarean Delivery 69 22.8 226 77.2 
NICU Admission 33 10.9 262 89.1 
Pre-pregnancy BMI (≥ 30 kg/m2) 56 18.7 239 81.3 
Note. BMI = Body Mass Index; NICU = Neonatal Intensive Care Unit. Some percentages do not add up to 




Specific Aim #1 
To examine the prevalence of SDB at time of delivery using the Facco Four 
Variable Model of SDB in pregnancy and the STOP-Bang score ≥3 in a general, third 
trimester, obstetric population who deliver at a large Military Treatment Facility (MTF).  
The prevalence of OSA in the sample was 12.3% (n=36) utilizing the Facco Four 
Variable (FFV) model and 7.1% (n=21) utilizing the STOP-Bang model. 
Specific Aim #2 
To examine if parturients suspected of having SDB as assessed by the Facco Four 
Variable Model (FFV; score ≥75) or the STOP-Bang score ≥ 3 have higher rates of the 
following perinatal maternal-infant outcomes: gestational hypertension, low birth weight, 
preeclampsia/eclampsia, gestational diabetes, cesarean delivery, hospital stay >5 days, a 
composite score of adverse pregnancy outcomes, and a composite score of cardiovascular 
complications that includes pulmonary embolism, in-hospital mortality, pulmonary 
edema, congestive heart failure, and cardiomyopathy. 
 Parametric and nonparametric tests were used to examine differences in being 
high-risk for SDB (FFV ≥75 or STOP-Bang ≥3) and demographic and clinical variables. 
Chi-square and Fischers Exact tests were used to examine the association between being 
high-risk for SDB and adverse pregnancy outcomes. Multivariable logistic regression 
was used to examine if the FFV model (≥75) was predictive of a composite adverse 
pregnancy outcomes variable while controlling for covariates. All potential covariate 
variables (primagravida, prior cesarean delivery, prior preeclampsia, advanced maternal 
age, chronic HTN, pregestational DM, obesity, and weight gain during pregnancy) were 
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entered into the model, those variables with a p > .10 were eliminated from the final 
model, p < .05 was significant. 
Facco Four Variable Model (FFV) demographics. Using the FFV, 12.3% of 
participants (n=36) screened positive with a score ≥ 75. Statistically significant 
differences were found in women who screened positive for SDB versus those who did 
not (Table 3). Women who screened positive on the FFV with a score ≥75 were found to 
be older (32.9 ± 5 years vs. 26.7 ± 4.7, p <.0001), to have a pre pregnancy BMI >30 
(61.1% vs. 12.8%, p <.0001), a higher delivery BMI (36.6± 5.1 vs 30.5±4.8, p <.0001), a 
larger neck circumference (37.7 cm±2.3 vs. 35.2 ±2.6 p <.0001), more chronic 
hypertension (19.4% vs. 1.6% p <.0001), and had a higher incidence of a previous 





Demographic and Clinical Characteristics by Facco Four Variable Model Categorical  
(N = 295) 
 Facco (+) n=36 Facco (-) n=259  
Variable M SD M SD t 
Age (years)    32.97     5.02 26.74     4.87 -7.16** 
Pre-Pregnancy BMI (kg/m2)   31.96     6.38 24.64     4.34 -8.87** 
Delivery BMI (kg/m2)   36.58     5.14 30.50     4.84 -7.00** 
Gestational Age (days) 273.78     9.74 275.39     9.65     0.94 
Neck Circumference (cm) 37.71     2.38 35.18     2.58 -5.91** 
 n % n % χ2 
Race       
White 19 50.0 135 51.5 
0.31 
Hispanic 42 16.0    7 18.4 
Black    6 15.8   37 14.1 
All Others   6 15.8   48 18.3 
Primigravida   7 19.4 101 39.3 5.35* 
Pre-pregnancy BMI ≥ 30 22 61.1   33 12.8 28.25** 
Chronic Hypertension   7 19.4    4   1.6   27.84** 
Prior Preeclampsia   4 11.1   10   3.9     3.56 
Pregestational Diabetes   0   0.0    3   0.2     0.43 
Prior Cesarean Delivery 32 30.6   11 12.5     8.12** 
Stop-Bang (+) 23 63.9   49 19.1   34.23** 
Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and % 
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic 
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score 
≥ 3 (high-risk for Obstructive Sleep Apnea). 
 
* p ≤ .05, ** p ≤ .001. 
 48 
 
Facco Four Variable Model (FFV) Chi-Square tests. Subjects who were 
considered high-risk for SDB based on the FFV (FFV ≥75) were found to have 
statistically significantly higher rates of adverse pregnancy outcomes (composite score = 
58.3% vs. 39.7%, p = .027). Women who screened positive for SBD using the FFV 
model had a statistically significant higher unadjusted rates of cesarean delivery (36.1% 
vs. 20.6%, p = .035; (Figure 2). (Table 4). Higher rates of gestational hypertension 
(16.7% vs. 9.3%, p = .14), gestational diabetes (8.3% vs. 5.1%, p = .31), and NICU 
admission (11.1% vs. 9.7%, p = .49) were found in subjects with FFV ≥75), but 






Figure 2. Adverse Pregnancy Outcomes by Facco Four Variable Model Categorical 
(N = 295). Facco (+) categorical score = Age (years) + Pre-pregnancy BMI (kg/m2) + 
Snoring ≥ 3 days/week (15 points) + Pre-pregnancy Hypertension (15 points). Facco (+) 
≥ 75 = positive screening for Sleep Disordered Breathing.  
 

























Adverse Pregnancy Outcomes by Facco Four Variable Model Categorical (N = 295)  
 Facco (+) n=36a Facco (-) n=254  
Variable n % n % χ2 
APO Composite Score b  21 58.3 103 40.1 4.31* 
Gestational Hypertension    6 16.7   24   9.3    1.85 
Gestational Diabetes   3   8.3   13   5.1    0.66 
Preeclampsia   3   8.3   24   9.3    0.04 
Preterm Delivery (< 37 weeks)   2   5.6   13   5.1    0.02 
Cesarean Delivery  13 36.1   53 20.6 4.34* 
Low Birth Weight (< 2500 g)   1   2.8   13   5.1    0.37 
NICU Admission   4 11.1   25   9.7    0.07 
Length of Stay at Hospital (> 5 
days) 
  1   2.8   12   4.7    0.53 
Note. APO = Adverse Pregnancy Outcomes; NICU = Neonatal Intensive Care Unit. This table only 
presents n and % values for the presence (coded “Yes” = 1)   of APO Composite Score, Gestational 
Hypertension, Gestational Diabetes, Preeclampsia, Preterm Delivery (< 37 weeks), Cesarean Delivery, Low 
Birth Weight (< 2500 g), NICU Admission, and Length of Stay at Hospital (> 5 days). Analysis excluded 
cases of twin delivery.  
 
a Facco (+) = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Pre-
pregnancy Hypertension (15 points). Facco (+) ≥ 75 = positive screening for Sleep Disordered Breathing.  
b APO Composite Score = “Yes,” if all APOs above are present.   
 
* p ≤ .05, ** p ≤ .001. 
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Logistic regression of Facco Four Variable categorical score (FFV +).  A test 
of full model against a constant only model was statistically significant using the FFV as 
a categorical variable, indicating predictors, as a set, reliably distinguished between those 
who had an adverse pregnancy outcome (X 2 = 33.286, p<.0001, df = 5). Hosmer-
Lemeshow test indicated the model was a good fit to the data, X 2  =7.342 df(4), p =.119. 
Nagelkerke’s R2 of .133 indicated a small relationship between prediction and grouping. 
The model correctly classified 64.6% of cases. The Wald criterion demonstrated 
primigravida, prior cesarean delivery (CSD), and prior preeclampsia made a significant 
contribution to the probability of a patient having a adverse pregnancy outcome (p<.05). 
The FFV (+) was not significantly associated with adverse pregnancy outcomes (B =.405, 




Table 5  
Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes 
Utilizing the Facco Four Variable Model Categorical Score. (N = 295) 
 Adverse Pregnancy Outcomes 
Predictor B SE B OR 95% CI 
Facco (+) a       0.595 .388 1.813 [0.85, 3.98] 
Primigravida       0.672* .273 1.958 [1.15, 3.35] 
Prior Cesarean Delivery 1.253** .381 3.499 [1.66, 7.38] 
Prior Preeclampsia 2.182** .794 8.864 
  [1.87, 
42.00] 
Constant -0.934** .197 0.393 -- 
     
χ2 28.89** 
df 4 
% APO 64.60 
Note. Facco (+) = Facco Four Variable Model Categorical Score (≥ 75); APO = Adverse Pregnancy 
Outcomes; OR = odds ratio; CI = confidence interval. The APO Composite Score variable includes the 
following risk factors; Gestational Hypertension, Preeclampsia, Gestational Diabetes, Cesarean Delivery, 
Low Birth Weight, NICU Admission, Preterm Delivery, and Hospital Stay (> 5 days). Analysis excluded 
cases of twin delivery. 
 
a Facco (+) = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Pre-
pregnancy Hypertension (15 points). Facco (+) ≥ 75 = positive screening for Sleep Disordered Breathing.  
 
* p ≤ .05, ** p ≤ .001. 
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Logistic regression Facco Four Variable–Absolute Score. A test of full model 
against a constant only model was statistically significant using the FFV as a continuous 
variable using the total score, indicating that predictors, as a set, reliably distinguished 
between those who had a adverse pregnancy outcome (X 2 = 32.678, p<.0001, df =4). 
Hosmer-Lemeshow test indicated the model was a good fit to the data, X 2 =7.971 df(8), 
p =.436. Nagelkerke’s R2 of .143 indicated a small relationship between prediction and 
grouping. The model correctly classified 66.3% of cases. The Wald criterion 
demonstrated FFV-AS, primagravida, prior cesarean delivery (CSD), and prior 
preeclampsia made a significant contribution to the probability of a patient having a 
adverse pregnancy outcome (p<.05). The FFV-AS was significantly associated with 
adverse pregnancy outcomes (B =.028, Wald = 6.193,p = .013, OR = 1.028, 95% CI = 
1.006-1.051). As the FFV-AS score increased, the odds of an adverse pregnancy outcome 





Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes 
Utilizing the Facco Four Variable Model Continuous Score. (N = 295) 
 Adverse Pregnancy Outcomes  
Predictor B SE B OR 95% CI 
Facco Score a       0.028* .011 1.028   [1.01, 1.05] 
Primigravida       0.684* .277 1.982   [1.15, 3.41] 
Prior Cesarean Delivery 1.094** .389 2.986   [1.39, 6.40] 
Prior Preeclampsia -2.212** .795 9.137   [1.93, 
Constant -2.499** .693 0.082 -- 
     
χ2 32.68** 
df 4 
% APO 66.30 
Note. Facco Score = Facco Four Variable Model Continuous Score; APO = Adverse Pregnancy Outcomes; 
OR = odds ratio; CI = confidence interval. The APO Composite Score variable includes the following risk 
factors; Gestational Hypertension, Preeclampsia, Gestational Diabetes, Cesarean Delivery, Low Birth 
Weight, NICU Admission, Preterm Delivery, and Hospital Stay (> 5 days). Analysis excluded cases of twin 
delivery. 
 
a Facco Score = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Pre-
pregnancy Hypertension (15 points).  
 
* p ≤ .05, ** p ≤ .001. 
 
STOP-BANG demographics. Compared to the 36 women who screened positive 
on the FFV, only 21 women screened positive on the STOP-Bang. Women who screened 
positive for SDB with a STOP-BANG ≥3 score had some significant differences from 
those that who did not. (Table 7), specifically weight and body mass index (BMI). Pre-
pregnancy weight (190.3 ± 39.3 vs. 147.6 ± 32.0 t (292) = 5.795, p = <.001), pre-
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pregnancy BMI (31.7 ± 6.3 vs. 25.1 ± 4.8, p = <.0001), delivery weight (224.7 ± 24.7 vs. 
181.0 ± 33.9, p = <.0001), and delivery BMI (37.6 ± 3.6 vs. 30.80 ± 5.1, p = <.0001), and 
pre-pregnancy BMI >30% (61.9 vs.15.4, p = <.0001). More women with chronic 
hypertension (14.3% vs. 2.9%, p = .036) screened positive, as well as those with a larger 
neck circumference (39.5 cm vs. 35.2 cm, t(292) = 7.667, p <.0001). Prepregnancy BMI 
>35, chronic hypertension, and age are all factors in the STOP-Bang model and greater 
percentages among women that screened positive with the instrument can be expected. A 
longer hospital stay was also noted among women who screened positive for SDB (4.0 ± 





Demographic and Clinical Characteristics by Stop-Bang Categorical (N = 295) 
 Stop-Bang (+) Stop-Bang (-)  
Variable M SD M SD t 
Age (years)    29.48  6.02  27.32     5.22   -1.80 
Pre-pregnancy BMI (kg/m2)   31.71  6.31  25.07     4.82 -5.95** 
Delivery BMI (kg/m2)   37.55  3.58  30.77     5.06 -6.02** 
Gestational Age (days) 273.62 11.36 275.31     9.50     0.78 
Neck Circumference (cm)   39.48  2.49  35.21     2.46 -7.67** 
 n % n % χ2 
Race       
White   8    38.1 148 52.7 
4.33 Hispanic   4    19.0   45 16.0 
Black    6    28.6   37 13.3 
All Others   3    14.3   51 18.1 
Primigravida   7    33.3   14 36.2 0.13 
Pre-pregnancy BMI ≥ 30 13    61.9   42 15.4 27.6** 
Chronic Hypertension   3    14.3    8   2.9    6.98** 
Prior Preeclampsia   1      4.8   13   4.8 0.00 
Pregestational Diabetes   0      0.0    3   1.1 0.23 
Prior Cesarean Delivery   4    19.0   39 14.3 0.35 
Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and % 
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic 
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score 
(+) ≥ 3 (high-risk for Obstructive Sleep Apnea).    
 
* p ≤ .05, ** p ≤ .001. 
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STOP-BANG Chi-Square tests. Subjects who were considered high-risk for 
SDB based on the STOP-Bang score ≥ 3 were found to have statistically significant 
higher rates of several adverse pregnancy outcomes (table 8): composite score (66.7% vs. 
40.9%, p = .019), gestational hypertension (33.3% vs. 8.4%, p = .002), and cesarean 
delivery (42.9% vs. 21.2, p = .027). Higher rates of preeclampsia (19.0% vs. 8.4%, p = 
.112) and low birth weight <2500 grams (9.5% vs. 4.8%, p = .293), and NICU admission 
(19.0% vs. 9.5%, p = .152), were found, but did not reach statistical significance. Similar 
rates of gestational diabetes (5.5% vs. 5.4%, p = .590), pre-term delivery less than 37 
weeks (4.8% vs. 5.1%, p = .710), and length of stay greater than 5 days (0% vs. 2.3%) 
were found in subjects with a STOP-Bang score ≥3. No participants experienced any 





Adverse Pregnancy Outcomes by Stop-Bang Categorical (N = 295)  
 Stop-Bang (+) a Stop-Bang (-)  
Variable n % n % χ2 
APO Composite Score b  14 66.7 112 40.9    5.30* 
Gestational Hypertension    7 33.3   23   8.4 13.28** 
Gestational Diabetes   1   4.8   15   5.5    0.02 
Preeclampsia   4 19.0   23   8.4    2.66 
Preterm Delivery (< 37 weeks)   1   4.8   14   5.1    0.01 
Cesarean Delivery    9 42.9   58 21.2 5.23* 
Low Birth Weight (< 2500 g)   2   9.5   13   4.8    0.90 
NICU Admission   4   9.5   26 19.0    1.95 
Length of Stay at Hospital (> 5 
days) 
  3 14.3   10   3.6    5.55 
Note. APO = Adverse Pregnancy Outcomes; NICU = Neonatal Intensive Care Unit. This table only 
presents n and % values for the presence (coded “Yes” = 1) of APO Composite Score, Gestational 
Hypertension, Gestational Diabetes, Preeclampsia, Preterm Delivery (< 37 weeks), Cesarean Delivery, Low 
Birth Weight (< 2500 g), NICU Admission, and Length of Stay at Hospital (> 5 days). Analysis excluded 
cases of twin delivery.  
 
a Stop-Bang (+) continuous score was calculated. A Stop-Bang (+) ≥ 3 indicated high-risk for Obstructive 
Sleep Apnea; a Stop-Bang (-) < 3 indicated low-risk for Obstructive Sleep Apnea.   
b APO Composite Score = “Yes,” if all APOs above are present.   
 




Logistic regression of STOP-BANG ≥3 = High Risk. A test of full model 
against a constant only model was statistically significant, indicating that predictors, as a 
set, reliably distinguished between those who had a adverse pregnancy outcome (X 2 = 
31.806, p<.0001, df =4). (Table 9) Hosmer-Lemeshow test indicated the model was a 
good fit to the data, X 2 =.088 df(2), p =.957. Nagelkerke’s R2 of .138 indicated a small 
relationship between prediction and grouping. The model correctly classified 65.5% of 
cases. The Wald criterion demonstrated SB High Risk, primagravida, prior cesarean 
delivery (CSD), and prior preeclampsia made a significant contribution to the probability 
of a patient having an adverse pregnancy outcome (p<.05). The SB High Risk was 
significantly associated with adverse pregnancy outcomes (B =1.167, Wald = 5.503, p = 
.019, OR = 3.211, 95% CI = 1.211-8.510). As the SB High Risk score increased, the odds 




Table 9  
Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes 
Utilizing the Stop-Bang Categorical Score. (N = 295) 
 Adverse Pregnancy Outcomes 
Predictor B SE B OR 95% CI 
Stop-Bang (+) a        1.167 .497  3.211  [1.21, 8.51] 
Primigravida 0.657 .273  1.928  [1.13, 3.29] 
Prior Cesarean Delivery 1.314 .380  3.721  [1.77, 7.84] 
Prior Preeclampsia 2.311 .796 10.081 [2.12, 47.98] 
Constant -0.932 .194  0.394 -- 
     
χ2 31.81** 
df 4 
% APO 65.50 
Note. APO = Adverse Pregnancy Outcomes; OR = odds ratio; CI = confidence interval. The APO 
Composite Score variable includes the following risk factors; Gestational Hypertension, Preeclampsia, 
Gestational Diabetes, Cesarean Delivery, Low Birth Weight, NICU Admission, Preterm Delivery, and 
Hospital Stay (> 5 days). Analysis excluded cases of twin delivery. 
 
a Stop-Bang (+) continuous score was calculated. A Stop-Bang (+) ≥ 3 indicated high-risk for Obstructive 
Sleep Apnea; a Stop-Bang score (-) < 3 indicated low-risk for Obstructive Sleep Apnea.   
 





Figure 3. Adverse Pregnancy Outcomes by Stop-Bang (+) (N = 295). Stop-Bang (+) ≥ 3 
indicated high-risk for Obstructive Sleep Apnea; a Stop-Bang (-) < 3 indicated low-risk 
for Obstructive Sleep Apnea.   






























Exploratory Aim. Compare demographic, outcomes data, and the prevalence 
rates of suspected SDB at delivery between active duty (AD) and non-active duty or 
dependent (DEP) parturients.  
Exploratory aim demographics. Of 294 participants, 38.6% (n=114) were active 
duty and 60.7% (n=179) were dependents (Table 10). An independent samples t-test was 
conducted on demographic and outcomes data and statistically significant differences 
were found between active duty and dependents in age and weight gained during 
pregnancy. Active duty participants were younger (M=25.55, SD=4.68) compared to 
dependents (M=28.71, SD=5.33), (t (291) = 5.179, p=.0001). Weight gain during 
pregnancy was greater among active duty (M=38.50 lbs, SD=15.19) compared to 
dependents (M=30.40 lbs, SD=13.54) t (285) =4.701, p=.0001. Active duty women were 
more likely to be primigravid (47.4%versus30.7%) Pearson X 2=8.859, df(2), p=.012. 
A significant association was noted between a positive FFV score and active duty 
status, with active duty subjects having significantly lower rates of SDB as defined by the 
FFV model (≥75; active duty: 16.7% (n=6) vs dependents: 83.3% (n=30) Pearson Chi-
Square = 8.663, df(2), p=.013). When utilizing the STOP-Bang instrument 7.1% (n=21) 
of participants screened positive for SDB. Of the 21 positive screenings, 42.9% (n=9) 
were active duty compared to 57.1% (n=12) dependents.  
For adverse pregnancy outcomes, 42.5% (n=125) of participants experienced an 
adverse pregnancy outcome. There was no association between active duty or dependent 
status and the rate of adverse pregnancy outcomes. Of the active duty participants, 39.5% 
(n=45) had an adverse pregnancy outcome while 44.7 % (n=80) of dependents 




Demographic and Clinical Characteristics of Study Population by Military Status (N = 
295) 
 Active Duty Dependents  
Variable M SD M SD t 
Age (years)     25.55     4.68   28.71 5.33 -5.18** 
Pre-Pregnancy BMI (kg/m2)    25.12     3.76   25.82 5.98    -1.11 
Delivery BMI (kg/m2)   31.62     4.51   31.07 5.71     0.87 
Gestational Age (days) 276.08     9.70 274.57 9.60     1.31 
Neck Circumference (cm)   35.55     2.54   35.50 2.80     0.16 
 n % n % χ2 
Race       
White   55 47.4 100    54.3 
  13.40* Hispanic   18 15.5   30    16.3 
Black    25 21.6   18      9.8 
All Others 116    100.0 184  100.0 
Primigravida   54 47.4   55    30.7 8.86* 
Pre-pregnancy BMI ≥ 30   16 13.9   40    21.9     3.16 
Chronic Hypertension     2   1.8     9      5.1     2.14 
Prior Preeclampsia     4    3.5   10      5.6     0.75 
Pregestational Diabetes     2   1.8     1      0.6     1.00 
Prior Cesarean Delivery     9   7.9   33    18.6  6.68* 
Stop-Bang (+)   26  22.8   47    26.3 0.78 
Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and % 
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic 
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score 
≥ 3 (+) (high-risk for Obstructive Sleep Apnea). 
 







In this study two different instruments were used to assess the prevalence of sleep 
disordered breathing (SDB) in a general pregnant population presenting for delivery at a 
tertiary care military treatment facility (MTF). The overall prevalence of sleep disordered 
breathing in the general population at time of delivery using the Facco Four Variable 
(FFV) model was 12.3% and 7.1% using STOP-Bang (SB). The FFV is relatively new 
and purpose-built for the obstetric population while SB was designed for the pre-
operative surgical population and is used extensively throughout the military health 
system in primary care and anesthesia preoperative clinics. Screening positive for SDB 
showed strong associations with gestational hypertension and cesarean delivery–both of 
which are morbidities with adverse effects on pregnancy outcomes. Pregnancy is a 
biologically active portion of a woman’s life that can have a profound influence on future 
health. The inflammation caused by SDB seem to have adverse physiological effects on a 
woman’s health and how her infant is delivered. This adds to the significance of our 
results and demonstrates a need to improve awareness, interventions for, and further 
research of SDB in the pregnant population. As we discovered, a significant percentage 
of women are at risk for SDB yet few are aware of this risk. All of the participants who 
screened positive were essentially undiagnosed cases of SDB as none had undergone 
screening or objective testing for SDB prior to participating in this study. This 
“unknown” risk is significant and, at first, surprising. However, SDB is underdiagnosed 
and underreported in women–especially during pregnancy (J. Louis, Auckley, & Bolden, 
2012). Another concern is the persistence of the SDB diagnosis after delivery. Does the 
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rapid reduction in weight and BMI resolve SDB? What is the relationship of SDB, sleep 
fragmentation, and fatigue in the postpartum period? There are many questions that still 
need to be investigated about SDB and pregnancy.  
The FFV was created, based on the Berlin questionnaire, to screen pregnant 
women at high risk for SDB (Facco et al., 2012). Pregnant women at increased risk for 
SDB may have chronic hypertension, pre-gestational diabetes, obesity, or prior a history 
of preeclampsia. The prevalence of SDB in populations with these risk factors can range 
from 15.4% (Pien et al., 2014) to over 45% (Facco et al., 2014). In this study, the FFV 
was applied to a general pregnant population and participants were not pre-selected based 
on attributes for increased risk of SDB. This is a unique aspect of this study and a new 
application for the FFV. Early studies, such as the Wisconsin Sleep Cohort Study 
(WSCS, Young, 1993), focused on the general adult population. The WSCS found an 
initial prevalence of SDB for adult women was 9%, much higher than the estimated 2% 
at the study’s inception, but still significantly less than the 24% prevalence for men 
(Young, 1993). The 12.3% prevalence found in our study suggests there may be an 
increased amount of SDB during pregnancy, which may be related to the weight gain and 
physiological changes of pregnancy which affect airway architecture. Because formal 
sleep studies were not performed, we cannot confirm patients enrolled had SDB, and it is 
unknown what percentage of them would have SDB symptoms resolve after pregnancy. 
It should be noted the first exclusion criteria for the Wisconsin Sleep Cohort Study was 
pregnancy and for enrollment the participants were between 30-60 years of age. The 
WSCS study was initiated over 20 years ago and the prevalence of obesity and SDB have 
since risen dramatically since then (J. M. Louis et al., 2014).  
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Increased body weight and body mass index (BMI) figured prominently in the 
study reported here. Both instruments include measures of BMI as factors to identify 
SDB risk and they highlight the relationship between body weight and SDB in 
pregnancy. For women who screened positive with the FFV, more presented with a pre-
pregnancy BMI >30, a larger neck circumference, and had a higher BMI at delivery than 
those who screened negative. Using SB, women who screened positive had a higher pre-
pregnancy weight, pre-pregnancy BMI, neck circumference, higher delivery weight and 
delivery BMI, and a greater percentage with a pre-pregnancy BMI >30. Complications of 
maternal obesity in pregnancy include gestational diabetes, preeclampsia, cesarean 
delivery, low apgar scores, and macrosomia (Ovesen et al., 2011). Patients screening 
positive on the FFV and SB had significantly higher rates of cesarean delivery, a finding 
consistent with obesity in pregnancy.  
For this study, a pre-pregnancy BMI >30 was noted in 18.7% of participants 
compared to a national prevalence of obesity (BMI ≥ 30%) reported as 35.8% among 
adult women (Flegal et al., 2012). Our sample contains 38.5% (n=116) active duty 
women who are required to maintain physical fitness and BMI standards as part of their 
military service. In addition, all participants have access to high quality healthcare 
through the Department of Defense, Military Health System and the study inclusion 
criteria required eligibility for care and enrollment in this system. Clinical settings with 
higher rates of obesity and possibly with less access to healthcare may have a greater 
prevalence of obesity and ultimately, SDB. Based on the results of this study, excess 




Results from this study must be viewed in light of the following limitations. This 
study lacks objective verification for the diagnosis of sleep disordered breathing. Both the 
FFV and SB are screening tools used to help make decisions about whether further 
diagnostic intervention is needed; neither is able to provide more than a suspected range 
for an apnea-hypopnea index value. While the FFV has been validated with PSG in a 
population at high-risk for SDB it has not been validated in the general obstetric 
population. Similarly, while SB has been extensively validated in the surgical population 
using PSG, there are limited studies that have been conducted in the obstetric population. 
Recently, a study compared SB with the Berlin questionnaire in each trimester of 
pregnancy in women recruited from a high-risk antenatal clinic in Thailand (Tantrakul et 
al., 2015).  A total of 72 women (23 first trimester, 24 second trimester, 25 third 
trimester) were recruited, completed both the Berlin and SB questionnaires, and then 
given an at-home, wrist worn, overnight sleep study.  The authors used a unique cutoff 
point of BMI >27.5 for SB that was determined to be culturally specific for their sample. 
The study found the sensitivity to identify patients with OSA was poor in the first 
trimester (sensitivity = 57.1%, specificity = 87.5%, PPV = 66.7%, NPV = 82.7%, AUC 
0.71, p = 0.23, CI 95% = 0.47-0.92), improved in the second trimester (sensitivity = 
62.5%, specificity = 93.8%, PPV = 83.3%, NPV = 83.3%, AUC 0.78, p = 0.23, CI 95% = 
0.47-0.92), and decreased in the third trimester (sensitivity = 62.5%, specificity = 88.2%, 
PPV = 71.4%, NPV = 83.3%, AUC 0.75, p = 0.04, CI 95% = 0.53-0.97). The high 
specificity in all three trimesters suggests patients who screened positive most likely had 
OSA, but the moderate sensitivity suggests we cannot be certain if a patient screened 
 68 
 
negative that they do not have OSA. The positive predictive value was the highest in the 
second trimester, with 83.3% screening SB positive having confirmed OSA based on an 
apnea hyponea index (AHI) ≥5 events per hour. This suggests the second trimester may 
be the best time to screen women for OSA; however, earlier screening during the first 
trimester may allow for earlier intervention. The decrease in the positive predictive value 
in the third trimester is somewhat counterintuitive given that weight gain during 
pregnancy, in the majority of cases, will increase until delivery. It would be expected that 
symptoms of SDB would peak during the third trimester with maximum weight, BMI, 
and symptoms occuring at delivery and most easily recognized. Comparatively, a recent 
study by Facco et al. (2014), found the prevalence of SDB increased during pregnancy 
among a cohort of women at high-risk for SDB. A prospective observational study 
involving 128 women screened as high-risk for developing SDB underwent an at-home 
sleep study at 6-20 weeks gestation and repeated in the third trimester. Worsening or 
increasing severity of SDB during pregnancy was noted in 27% of the population and the 
incidence of new-onset SDB was 20%.  One explanation for this difference may be that 
in the Tantrakul et al. (2015) study, a single cohort of women was not followed 
throughout pregnancy. The dynamic process and continuous changes throughout 
pregnancy may require continuous monitoring and screening for optimal risk assessment 
regardless of the instrument used. The SB instrument, well known for ease of use and 
reliability in the surgical population, will require further validation and refinement for use 
during pregnancy.  
Self-reporting of symptoms and co-morbidities is another limitation of this study. 
Participants were asked to self-report the loudness of their snoring and the presence of 
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apneic episodes that occur while the participant is asleep. The case report form included 
questions to elicit a bed partner or roommate’s assessment of snoring and apneic 
episodes. Overall, 90.3% of respondents reported having a bed partner, 3% reported a 
partner/roommate in another room, and 6.7% reported no bed partner or roommate at all. 
Participants were not monitored during completion of the case report form and bed 
partner or roommate participation was not verified. There is some evidence of 
disagreement in which the self-report was negative for symptoms while the bed partner’s 
report was positive for symptoms and vice-versa. Without direct engagement of the bed 
partner or roommate it is difficult to ascertain their involvement in the completion of the 
case report form and accuracy of responses. An objective and quantifiable measure of 
SDB, such as an at-home sleep study, would have greatly strengthened the results.  
There are several types of hypertension during pregnancy: chronic hypertension, 
preeclampsia-eclampsia, chronic hypertension with superimposed preeclampsia, 
gestational hypertension, and postpartum hypertension (American College of 
Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy & American 
College of Obstetricians and Gynecologists, 2013). For this study, only chronic 
hypertension prior to pregnancy was used in scoring of the instruments. Both the FFV 
and SB instruments are derived from the Berlin questionnaire to screen for SDB/OSA but 
in different populations. FFV focused on women at high risk for SDB during pregnancy 
and SB for OSA in the surgical population (Chung et al., 2008b; Facco et al., 2012). The 
Berlin Questionnaire uses chronic hypertension as a factor in screening for OSA and was 
designed for primary care settings (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999). This 
methodology has been carried over in the wording of both instruments in this study as 
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“chronic hypertension” and “high blood pressure” were used in the case report form 
without discussion of “preeclampsia-eclampsia” or “gestational hypertension”. The 
diagnosis of chronic hypertension came from the physician’s history and physical as 
reported in the medical record. Including gestational hypertension and preeclampsia in 
this study most likely would have resulted in a greater percentage of women screened as 
“positive” for SDB, but not necessarily improved the sensitivity and specificity of the 
instruments. Chronic hypertension has a different physiologic mechanism than 
gestational hypertension and preeclampsia despite the common outcome of elevated 
systemic blood pressure. This may have been the reason for the decreased sensitivity of 
SB noted by Tantrakul et al (2015). Of the 72 women enrolled, 13 (18.1%) had 
hypertension. However, chronic hypertension was diagnosed in just 2 participants while 
11 were diagnosed with preeclampsia. There may still be a relationship between SDB and 
the hypertensive disorders of pregnancy. Future studies should include methodology to 
parse out such differences.  
Despite these limitations, findings from this study advances our understanding of 
strategies for screening for SDB during pregnancy.  Overall, the study found a prevalence 
of SDB by the Facco Four Variable Model of 12.3% and 7.1% by the STOP-Bang model 
in the general pregnant population presenting for delivery at a large military treatment 
facility. Strong associations with cesarean delivery and gestational hypertension were 
noted. Obesity continues to play a role in SDB as those who screened positive with either 
model were more likely to have elevations of weight and or BMI both in the beginning of 
pregnancy and at delivery. The study population was unique with 38.5% active duty 
military members who are required to meet specific health requirements for weight and 
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BMI. The prevalence of obesity was almost half of a national estimate and all of the 
participants had access to high quality healthcare throughout pregnancy.  
Conclusion 
Routine screening for SDB during pregnancy utilizing the FFV model should be 
conducted. Increased awareness of SDB and the effects of sleep on overall health is noted 
in scientific and popular literature. In the past, a lack of screening tools specific to the 
population under study and the use of clinic-based polysomnography (PSG) were 
obstacles that had to be overcome in order to diagnose and treat SDB. New technology 
has brought the ability to conduct at-home sleep studies that rival clinic based PSG- 
possibly the most important recent advance in sleep medicine. The at-home monitors are 
less expensive, applied by the patient, and physically less of a burden to sleep with 
(Facco et al., 2012). These new devices may facilitate research by providing more 
objective, quantifiable information about SDB. An at-home testing device could facilitate 
the development of more accurate screening instruments, a lower threshold for testing, 
earlier detection and the opportunity for repeated testing to track progression, treatment, 
and resolution of SDB. Further research is needed to determine critical points in the 
development and management of SDB during pregnancy, if or when SDB resolves after 
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